NRX Pharmaceuticals
NRXP
NRXP
20 hedge funds and large institutions have $44.1M invested in NRX Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.25% more ownership
Funds ownership: 4.73% → 4.98% (+0.25%)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$972K | |
| 2 | +$600K | |
| 3 | +$396K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$349K |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$242K |
Top Sellers
| 1 | -$202K | |
| 2 | -$122K | |
| 3 | -$19K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13K |